Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans

Authors: Eleni Aklillu, Linda Odenthal-Hesse, Jennifer Bowdrey, Abiy Habtewold, Eliford Ngaimisi, Getnet Yimer, Wondwossen Amogne, Sabina Mugusi, Omary Minzi, Eyasu Makonnen, Mohammed Janabi, Ferdinand Mugusi, Getachew Aderaye, Robert Hardwick, Beiyuan Fu, Maria Viskaduraki, Fengtang Yang, Edward J Hollox

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

The role of copy number variation of the CCL3L1 gene, encoding MIP1α, in contributing to the host variation in susceptibility and response to HIV infection is controversial. Here we analyse a sub-Saharan African cohort from Tanzania and Ethiopia, two countries with a high prevalence of HIV-1 and a high co-morbidity of HIV with tuberculosis.

Methods

We use a form of quantitative PCR called the paralogue ratio test to determine CCL3L1 gene copy number in 1134 individuals and validate our copy number typing using array comparative genomic hybridisation and fiber-FISH.

Results

We find no significant association of CCL3L1 gene copy number with HIV load in antiretroviral-naïve patients prior to initiation of combination highly active anti-retroviral therapy. However, we find a significant association of low CCL3L1 gene copy number with improved immune reconstitution following initiation of highly active anti-retroviral therapy (p = 0.012), replicating a previous study.

Conclusions

Our work supports a role for CCL3L1 copy number in immune reconstitution following antiretroviral therapy in HIV, and suggests that the MIP1α -CCR5 axis might be targeted to aid immune reconstitution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006, 3 (11): e442-10.1371/journal.pmed.0030442.CrossRefPubMedPubMedCentral Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine. 2006, 3 (11): e442-10.1371/journal.pmed.0030442.CrossRefPubMedPubMedCentral
2.
go back to reference An P, Winkler CA: Host genes associated with HIV/AIDS: advances in gene discovery. Trends in Genetics. 2010, 26 (3): 119-131. 10.1016/j.tig.2010.01.002.CrossRefPubMedPubMedCentral An P, Winkler CA: Host genes associated with HIV/AIDS: advances in gene discovery. Trends in Genetics. 2010, 26 (3): 119-131. 10.1016/j.tig.2010.01.002.CrossRefPubMedPubMedCentral
3.
go back to reference Petrovski S, Fellay J, Shianna KV, Carpenetti N, Kumwenda J, Kamanga G, Kamwendo DD, Letvin NL, McMichael AJ, Haynes BF, et al: Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS. 2011, 25 (4): 513-518. 10.1097/QAD.0b013e328343817b.CrossRefPubMedPubMedCentral Petrovski S, Fellay J, Shianna KV, Carpenetti N, Kumwenda J, Kamanga G, Kamwendo DD, Letvin NL, McMichael AJ, Haynes BF, et al: Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS. 2011, 25 (4): 513-518. 10.1097/QAD.0b013e328343817b.CrossRefPubMedPubMedCentral
4.
go back to reference Locke DP, Sharp AJ, McCarroll SA, McGrath SD, Newman TL, Cheng Z, Schwartz S, Albertson DG, Pinkel D, Altshuler DM, et al: Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. American Journal of Human Genetics. 2006, 79 (2): 275-290. 10.1086/505653.CrossRefPubMedPubMedCentral Locke DP, Sharp AJ, McCarroll SA, McGrath SD, Newman TL, Cheng Z, Schwartz S, Albertson DG, Pinkel D, Altshuler DM, et al: Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. American Journal of Human Genetics. 2006, 79 (2): 275-290. 10.1086/505653.CrossRefPubMedPubMedCentral
5.
go back to reference Wain LV, Armour JAL, Tobin MD: Genomic copy number variation, human health, and disease. Lancet. 2009, 374 (9686): 340-350. 10.1016/S0140-6736(09)60249-X.CrossRefPubMed Wain LV, Armour JAL, Tobin MD: Genomic copy number variation, human health, and disease. Lancet. 2009, 374 (9686): 340-350. 10.1016/S0140-6736(09)60249-X.CrossRefPubMed
6.
go back to reference Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, et al: Origins and functional impact of copy number variation in the human genome. Nature. 2009, 464 (7289): 704-712.CrossRefPubMedPubMedCentral Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, Aerts J, Andrews TD, Barnes C, Campbell P, et al: Origins and functional impact of copy number variation in the human genome. Nature. 2009, 464 (7289): 704-712.CrossRefPubMedPubMedCentral
7.
go back to reference Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, De Grassi A, Lee C, et al: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007, 315 (5813): 848-853. 10.1126/science.1136678.CrossRefPubMedPubMedCentral Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, De Grassi A, Lee C, et al: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007, 315 (5813): 848-853. 10.1126/science.1136678.CrossRefPubMedPubMedCentral
8.
go back to reference Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM, et al: Copy Number Variation of KIR Genes Influences HIV-1 Control. PLoS Biology. 2011, 9 (11): e1001208-10.1371/journal.pbio.1001208.CrossRefPubMedPubMedCentral Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, Ge D, De Luca A, Martinez-Picado J, Wolinsky SM, et al: Copy Number Variation of KIR Genes Influences HIV-1 Control. PLoS Biology. 2011, 9 (11): e1001208-10.1371/journal.pbio.1001208.CrossRefPubMedPubMedCentral
9.
go back to reference Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, et al: β-defensin Genomic Copy Number Is Associated With HIV Load and Immune Reconstitution in Sub-Saharan Africans. J Infect Dis. 2012, 206 (7): 1012-1019. 10.1093/infdis/jis448.CrossRefPubMed Hardwick RJ, Amogne W, Mugusi S, Yimer G, Ngaimisi E, Habtewold A, Minzi O, Makonnen E, Janabi M, Machado LR, et al: β-defensin Genomic Copy Number Is Associated With HIV Load and Immune Reconstitution in Sub-Saharan Africans. J Infect Dis. 2012, 206 (7): 1012-1019. 10.1093/infdis/jis448.CrossRefPubMed
10.
go back to reference Townson JR, Barcellos LF, Nibbs RJ: Gene copy number regulates the production of the human chemokine CCL3‒L1. European Journal of Immunology. 2002, 32 (10): 3016-3026. 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D.CrossRefPubMed Townson JR, Barcellos LF, Nibbs RJ: Gene copy number regulates the production of the human chemokine CCL3‒L1. European Journal of Immunology. 2002, 32 (10): 3016-3026. 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D.CrossRefPubMed
11.
go back to reference Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, et al: The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science Signalling. 2005, 307 (5714): 1434- Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, et al: The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science Signalling. 2005, 307 (5714): 1434-
12.
go back to reference Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O’Connell RJ, Marconi VC, Delmar J, Eron J, et al: CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals. Nature Medicine. 2008, 14 (4): 413-420. 10.1038/nm1741.CrossRefPubMedPubMedCentral Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O’Connell RJ, Marconi VC, Delmar J, Eron J, et al: CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1–infected individuals. Nature Medicine. 2008, 14 (4): 413-420. 10.1038/nm1741.CrossRefPubMedPubMedCentral
13.
go back to reference Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D, Proost P, Van Damme J: The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine. J Clin Investig. 1999, 104 (4): R1-10.1172/JCI7318.CrossRefPubMedPubMedCentral Menten P, Struyf S, Schutyser E, Wuyts A, De Clercq E, Schols D, Proost P, Van Damme J: The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine. J Clin Investig. 1999, 104 (4): R1-10.1172/JCI7318.CrossRefPubMedPubMedCentral
14.
15.
go back to reference Picton AC, Paximadis M, Tiemessen CT: Contribution of variable CCL3L copy number to CCL3 protein production in two ethnically divergent South African populations. Infect Genet Evol. 2013, 14: 347-356.CrossRefPubMed Picton AC, Paximadis M, Tiemessen CT: Contribution of variable CCL3L copy number to CCL3 protein production in two ethnically divergent South African populations. Infect Genet Evol. 2013, 14: 347-356.CrossRefPubMed
16.
go back to reference Proost P, Menten P, Struyf S, Schutyser E, De Meester I, Van Damme J: Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood. 2000, 96 (5): 1674-1680.PubMed Proost P, Menten P, Struyf S, Schutyser E, De Meester I, Van Damme J: Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78β into a most efficient monocyte attractant and CCR1 agonist. Blood. 2000, 96 (5): 1674-1680.PubMed
17.
go back to reference Menten P, Wuyts A, Van Damme J: Macrophage inflammatory protein-1. Cytokine & Growth Factor Reviews. 2002, 13 (6): 455-481. 10.1016/S1359-6101(02)00045-X.CrossRef Menten P, Wuyts A, Van Damme J: Macrophage inflammatory protein-1. Cytokine & Growth Factor Reviews. 2002, 13 (6): 455-481. 10.1016/S1359-6101(02)00045-X.CrossRef
18.
go back to reference Liu S, Yao L, Ding D, Zhu H: CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis. PLoS ONE. 2010, 5 (12): e15778-10.1371/journal.pone.0015778.CrossRefPubMedPubMedCentral Liu S, Yao L, Ding D, Zhu H: CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis. PLoS ONE. 2010, 5 (12): e15778-10.1371/journal.pone.0015778.CrossRefPubMedPubMedCentral
19.
go back to reference Cantsilieris S, White SJ: Correlating multiallelic copy number polymorphisms with disease susceptibility. Hum Mutat. 2012, 34: 1-13.CrossRefPubMed Cantsilieris S, White SJ: Correlating multiallelic copy number polymorphisms with disease susceptibility. Hum Mutat. 2012, 34: 1-13.CrossRefPubMed
20.
go back to reference Shrestha S, Nyaku M, Edberg JC: Variations in CCL3L gene cluster sequence and non-specific gene copy numbers. BMC Research Notes. 2010, 3 (1): 74-10.1186/1756-0500-3-74.CrossRefPubMedPubMedCentral Shrestha S, Nyaku M, Edberg JC: Variations in CCL3L gene cluster sequence and non-specific gene copy numbers. BMC Research Notes. 2010, 3 (1): 74-10.1186/1756-0500-3-74.CrossRefPubMedPubMedCentral
21.
go back to reference Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JA, Clayton DG, Todd JA: Experimental aspects of copy number variant assays at CCL3L1. Nat Med. 2009, 15 (10): 1115-1117. 10.1038/nm1009-1115.CrossRefPubMedPubMedCentral Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JA, Clayton DG, Todd JA: Experimental aspects of copy number variant assays at CCL3L1. Nat Med. 2009, 15 (10): 1115-1117. 10.1038/nm1009-1115.CrossRefPubMedPubMedCentral
22.
go back to reference Carpenter D, Walker S, Prescott N, Schalkwijk J, Armour JA: Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genomics. 2011, 12 (1): 418-10.1186/1471-2164-12-418.CrossRefPubMedPubMedCentral Carpenter D, Walker S, Prescott N, Schalkwijk J, Armour JA: Accuracy and differential bias in copy number measurement of CCL3L1 in association studies with three auto-immune disorders. BMC Genomics. 2011, 12 (1): 418-10.1186/1471-2164-12-418.CrossRefPubMedPubMedCentral
23.
go back to reference Walker S, Janyakhantikul S, Armour JA: Multiplex Paralogue Ratio Tests for accurate measurement of multiallelic CNVs. Genomics. 2009, 93 (1): 98-103. 10.1016/j.ygeno.2008.09.004.CrossRefPubMed Walker S, Janyakhantikul S, Armour JA: Multiplex Paralogue Ratio Tests for accurate measurement of multiallelic CNVs. Genomics. 2009, 93 (1): 98-103. 10.1016/j.ygeno.2008.09.004.CrossRefPubMed
24.
go back to reference Mamtani M, Mummidi S, Ramsuran V, Pham M-H, Maldonado R, Begum K, Valera MS, Sanchez R, Castiblanco J, Kulkarni H, et al: Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population. J Infect Dis. 2011, 203 (11): 1590-1594. 10.1093/infdis/jir145.CrossRefPubMedPubMedCentral Mamtani M, Mummidi S, Ramsuran V, Pham M-H, Maldonado R, Begum K, Valera MS, Sanchez R, Castiblanco J, Kulkarni H, et al: Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population. J Infect Dis. 2011, 203 (11): 1590-1594. 10.1093/infdis/jir145.CrossRefPubMedPubMedCentral
25.
go back to reference Li H, Xie H-Y, Zhou L, Wang W-L, Liang T-B, Zhang M, Zheng S-S: Polymorphisms of CCL3L1/CCR5 genes and recurrence of hepatitis B in liver transplant recipients. Hepatobiliary Pancreat Dis Int. 2011, 10 (6): 593-598. 10.1016/S1499-3872(11)60101-X.CrossRefPubMed Li H, Xie H-Y, Zhou L, Wang W-L, Liang T-B, Zhang M, Zheng S-S: Polymorphisms of CCL3L1/CCR5 genes and recurrence of hepatitis B in liver transplant recipients. Hepatobiliary Pancreat Dis Int. 2011, 10 (6): 593-598. 10.1016/S1499-3872(11)60101-X.CrossRefPubMed
26.
go back to reference Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F: Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. Journal of Hepatology. 2010, 52 (2): 153-159. 10.1016/j.jhep.2009.11.001.CrossRefPubMed Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F: Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C. Journal of Hepatology. 2010, 52 (2): 153-159. 10.1016/j.jhep.2009.11.001.CrossRefPubMed
27.
go back to reference Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, He W, Ahuja SK: Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS ONE. 2010, 5 (7): e11458-10.1371/journal.pone.0011458.CrossRefPubMedPubMedCentral Mamtani M, Matsubara T, Shimizu C, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, He W, Ahuja SK: Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS ONE. 2010, 5 (7): e11458-10.1371/journal.pone.0011458.CrossRefPubMedPubMedCentral
28.
go back to reference Kim H-E, Kim J-J, Han MK, Lee K-Y, Song MS, Lee H-D, Kim DS, Yu JJ, Park I-S, Yun SW, et al: Variations in the Number of CCL3L1 Gene Copies and Kawasaki Disease in Korean Children. Pediatr Cardiol. 2012, 1: 5- Kim H-E, Kim J-J, Han MK, Lee K-Y, Song MS, Lee H-D, Kim DS, Yu JJ, Park I-S, Yun SW, et al: Variations in the Number of CCL3L1 Gene Copies and Kawasaki Disease in Korean Children. Pediatr Cardiol. 2012, 1: 5-
29.
go back to reference Carpenter D, Färnert A, Rooth I, Armour JA, Shaw M-A: CCL3L1 copy number and susceptibility to malaria. Infect Genet Evol. 2012, 12: 1147-1154. 10.1016/j.meegid.2012.03.021.CrossRefPubMedPubMedCentral Carpenter D, Färnert A, Rooth I, Armour JA, Shaw M-A: CCL3L1 copy number and susceptibility to malaria. Infect Genet Evol. 2012, 12: 1147-1154. 10.1016/j.meegid.2012.03.021.CrossRefPubMedPubMedCentral
30.
go back to reference Larsen MH, Thørner LW, Zinyama R, Amstrup J, Kallestrup P, Gerstoft J, Gomo E, Erikstrup C, Ullum H: CCL3L gene copy number and survival in an HIV-1 infected Zimbabwean population. Infect Genet Evol. 2012, 12: 1087-1093. 10.1016/j.meegid.2012.03.013.CrossRefPubMed Larsen MH, Thørner LW, Zinyama R, Amstrup J, Kallestrup P, Gerstoft J, Gomo E, Erikstrup C, Ullum H: CCL3L gene copy number and survival in an HIV-1 infected Zimbabwean population. Infect Genet Evol. 2012, 12: 1087-1093. 10.1016/j.meegid.2012.03.013.CrossRefPubMed
31.
go back to reference Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT: African infants’ CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007, 21 (13): 1753-1761. 10.1097/QAD.0b013e3282ba553a.CrossRefPubMedPubMedCentral Kuhn L, Schramm DB, Donninger S, Meddows-Taylor S, Coovadia AH, Sherman GG, Gray GE, Tiemessen CT: African infants’ CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007, 21 (13): 1753-1761. 10.1097/QAD.0b013e3282ba553a.CrossRefPubMedPubMedCentral
32.
go back to reference Yimer G, Ueda N, Habtewold A, Amogne W, Suda A, Riedel K-D, Burhenne J, Aderaye G, Lindquist L, Makonnen E: Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients. PLoS ONE. 2011, 6 (12): e27810-10.1371/journal.pone.0027810.CrossRefPubMedPubMedCentral Yimer G, Ueda N, Habtewold A, Amogne W, Suda A, Riedel K-D, Burhenne J, Aderaye G, Lindquist L, Makonnen E: Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients. PLoS ONE. 2011, 6 (12): e27810-10.1371/journal.pone.0027810.CrossRefPubMedPubMedCentral
33.
go back to reference Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG: Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antiviral Therapy. 2012, 17 (2): 265-274.CrossRefPubMed Mugusi SF, Ngaimisi E, Janabi MY, Mugusi FM, Minzi OM, Sasi PG, Bakari M, Lindquist L, Aklillu E, Sandstrom EG: Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania. Antiviral Therapy. 2012, 17 (2): 265-274.CrossRefPubMed
34.
go back to reference Barnes C, Plagnol V, Fitzgerald T, Redon R, Marchini J, Clayton D, Hurles ME: A robust statistical method for case–control association testing with copy number variation. Nat Genet. 2008, 40 (10): 1245-1252. 10.1038/ng.206.CrossRefPubMedPubMedCentral Barnes C, Plagnol V, Fitzgerald T, Redon R, Marchini J, Clayton D, Hurles ME: A robust statistical method for case–control association testing with copy number variation. Nat Genet. 2008, 40 (10): 1245-1252. 10.1038/ng.206.CrossRefPubMedPubMedCentral
35.
go back to reference Perry GH, Yang F, Marques-Bonet T, Murphy C, Fitzgerald T, Lee AS, Hyland C, Stone AC, Hurles ME, Tyler-Smith C, et al: Copy number variation and evolution in humans and chimpanzees. Genome Res. 2008, 18 (11): 1698-1710. 10.1101/gr.082016.108.CrossRefPubMedPubMedCentral Perry GH, Yang F, Marques-Bonet T, Murphy C, Fitzgerald T, Lee AS, Hyland C, Stone AC, Hurles ME, Tyler-Smith C, et al: Copy number variation and evolution in humans and chimpanzees. Genome Res. 2008, 18 (11): 1698-1710. 10.1101/gr.082016.108.CrossRefPubMedPubMedCentral
36.
go back to reference Corbeau P, Reynes J: Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood. 2011, 117 (21): 5582-5590. 10.1182/blood-2010-12-322453.CrossRefPubMed Corbeau P, Reynes J: Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood. 2011, 117 (21): 5582-5590. 10.1182/blood-2010-12-322453.CrossRefPubMed
37.
go back to reference Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, Richard T, Unutmaz D, Benson CA, Ritchie MD, Landay A, et al: Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an AIDS Clinical Trials Group study. J Infect Dis. 2006, 194 (8): 1098-1107. 10.1086/507313.CrossRefPubMed Haas DW, Geraghty DE, Andersen J, Mar J, Motsinger AA, Richard T, Unutmaz D, Benson CA, Ritchie MD, Landay A, et al: Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: an AIDS Clinical Trials Group study. J Infect Dis. 2006, 194 (8): 1098-1107. 10.1086/507313.CrossRefPubMed
38.
go back to reference Bhattacharya T, Stanton J, Kim E-Y, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM: Ccl3l1 and hiv/aids susceptibility. Nature Medicine. 2009, 15 (10): 1112-1115. 10.1038/nm1009-1112.CrossRefPubMed Bhattacharya T, Stanton J, Kim E-Y, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM: Ccl3l1 and hiv/aids susceptibility. Nature Medicine. 2009, 15 (10): 1112-1115. 10.1038/nm1009-1112.CrossRefPubMed
39.
go back to reference Frittoli E, Palamidessi A, Pizzigoni A, Lanzetti L, Garrè M, Troglio F, Troilo A, Fukuda M, Di Fiore PP, Scita G, et al: The primate-specific protein TBC1D3 is required for optimal macropinocytosis in a novel ARF6-dependent pathway. Molecular Biology of the Cell. 2008, 19 (4): 1304-1316. 10.1091/mbc.E07-06-0594.CrossRefPubMedPubMedCentral Frittoli E, Palamidessi A, Pizzigoni A, Lanzetti L, Garrè M, Troglio F, Troilo A, Fukuda M, Di Fiore PP, Scita G, et al: The primate-specific protein TBC1D3 is required for optimal macropinocytosis in a novel ARF6-dependent pathway. Molecular Biology of the Cell. 2008, 19 (4): 1304-1316. 10.1091/mbc.E07-06-0594.CrossRefPubMedPubMedCentral
40.
go back to reference Kulkarni H, Okulicz JF, Grandits G, Crum-Cianflone NF, Landrum ML, Hale B, Wortmann G, Tramont E, Polis M, Dolan M: Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2011, 57 (5): 387-395. 10.1097/QAI.0b013e3182219113.CrossRefPubMed Kulkarni H, Okulicz JF, Grandits G, Crum-Cianflone NF, Landrum ML, Hale B, Wortmann G, Tramont E, Polis M, Dolan M: Early Postseroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1–Postive Subjects Receiving Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2011, 57 (5): 387-395. 10.1097/QAI.0b013e3182219113.CrossRefPubMed
Metadata
Title
CCL3L1 copy number, HIV load, and immune reconstitution in sub-Saharan Africans
Authors
Eleni Aklillu
Linda Odenthal-Hesse
Jennifer Bowdrey
Abiy Habtewold
Eliford Ngaimisi
Getnet Yimer
Wondwossen Amogne
Sabina Mugusi
Omary Minzi
Eyasu Makonnen
Mohammed Janabi
Ferdinand Mugusi
Getachew Aderaye
Robert Hardwick
Beiyuan Fu
Maria Viskaduraki
Fengtang Yang
Edward J Hollox
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-536

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.